Novel nonadride, heptadride and maleic acid metabolites from the byssochlamic acid producer Byssochlamys fulva IMI 40021 - an insight into the biosynthesis of maleidrides.
Novel nonadride, heptadride and maleic acid metabolites from the byssochlamic acid producer Byssochlamys fulva IMI 40021 - an insight into the biosynthesis of maleidrides.
复制标题
DOI:
10.1039/c5cc06988b
复制
发表时间:
2015-12-14
期刊:
影响因子:
--
通讯作者:
Simpson TJ
中科院分区:
文献类型:
--
作者:
Szwalbe AJ;Williams K;O'Flynn DE;Bailey AM;Mulholland NP;Vincent JL;Willis CL;Cox RJ;Simpson TJ
Byssochlamic acid and the novel heptadride, agnestadride A are biosynthesised via alternative dimerisations of a maleic acid monomer. The filamentous fungus Byssochlamys fulva strain IMI 40021 produces (+)-byssochlamic acid 1, its novel dihydroanalogue 2 and four related secondary metabolites. Agnestadrides A, 17 and B, 18 constitute a novel class of seven-membered ring, maleic anhydride-containing (hence termed heptadride) natural products. The putative maleic anhydride precursor 5 for both nonadride and heptadride biosynthesis was isolated as a fermentation product for the first time and its structure confirmed by synthesis. Acid 5 undergoes facile decarboxylation to anhydride 6. The generic term maleidrides is proposed to encompass biosynthetically-related compounds containing maleic anhydride moieties fused to an alicyclic ring, varying in size and substituents.